Annual Net Income
-$81.41 M
-$26.82 M-49.12%
31 December 2023
Summary:
Leap Therapeutics annual net profit is currently -$81.41 million, with the most recent change of -$26.82 million (-49.12%) on 31 December 2023. During the last 3 years, it has fallen by -$53.90 million (-195.90%). LPTX annual net income is now -949.69% below its all-time high of -$7.76 million, reached on 31 December 2012.LPTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$18.18 M
+$1.95 M+9.70%
30 September 2024
Summary:
Leap Therapeutics quarterly net profit is currently -$18.18 million, with the most recent change of +$1.95 million (+9.70%) on 30 September 2024. Over the past year, it has dropped by -$4.48 million (-32.71%). LPTX quarterly net income is now -347.09% below its all-time high of $7.36 million, reached on 31 December 2015.LPTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$64.59 M
-$4.48 M-7.45%
30 September 2024
Summary:
Leap Therapeutics TTM net profit is currently -$64.59 million, with the most recent change of -$4.48 million (-7.45%) on 30 September 2024. Over the past year, it has increased by +$16.46 million (+20.31%). LPTX TTM net income is now -3310.19% below its all-time high of -$1.89 million, reached on 31 March 2013.LPTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.1% | -32.7% | +20.3% |
| 3 y3 years | -195.9% | -63.2% | -76.9% |
| 5 y5 years | -251.9% | -129.1% | -175.7% |
LPTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -195.9% | at low | -75.2% | +56.6% | -76.9% | +25.0% |
| 5 y | 5 years | -251.9% | at low | -178.9% | +56.6% | -175.7% | +25.0% |
| alltime | all time | -949.7% | at low | -347.1% | +56.6% | -3310.2% | +25.0% |
Leap Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.18 M(-9.7%) | -$64.59 M(+7.5%) |
| June 2024 | - | -$20.13 M(+45.6%) | -$60.11 M(+12.6%) |
| Mar 2024 | - | -$13.82 M(+10.9%) | -$53.37 M(-34.4%) |
| Dec 2023 | -$81.41 M(+49.1%) | -$12.46 M(-9.0%) | -$81.41 M(+0.4%) |
| Sept 2023 | - | -$13.70 M(+2.3%) | -$81.05 M(-1.7%) |
| June 2023 | - | -$13.39 M(-68.0%) | -$82.45 M(-4.2%) |
| Mar 2023 | - | -$41.86 M(+245.9%) | -$86.08 M(+57.7%) |
| Dec 2022 | -$54.60 M(+34.5%) | -$12.10 M(-19.8%) | -$54.60 M(+2.5%) |
| Sept 2022 | - | -$15.09 M(-11.3%) | -$53.28 M(+8.0%) |
| June 2022 | - | -$17.02 M(+64.1%) | -$49.33 M(+17.9%) |
| Mar 2022 | - | -$10.38 M(-3.8%) | -$41.83 M(+3.1%) |
| Dec 2021 | -$40.59 M(+47.5%) | -$10.79 M(-3.2%) | -$40.59 M(+11.2%) |
| Sept 2021 | - | -$11.14 M(+16.9%) | -$36.51 M(+12.6%) |
| June 2021 | - | -$9.53 M(+4.3%) | -$32.43 M(+10.2%) |
| Mar 2021 | - | -$9.13 M(+36.1%) | -$29.42 M(+6.9%) |
| Dec 2020 | -$27.51 M(-16.4%) | -$6.71 M(-4.9%) | -$27.51 M(-4.5%) |
| Sept 2020 | - | -$7.06 M(+8.3%) | -$28.80 M(-3.0%) |
| June 2020 | - | -$6.52 M(-9.9%) | -$29.68 M(-5.9%) |
| Mar 2020 | - | -$7.23 M(-9.6%) | -$31.53 M(-4.2%) |
| Dec 2019 | -$32.90 M(+42.2%) | -$8.00 M(+0.8%) | -$32.90 M(+40.5%) |
| Sept 2019 | - | -$7.93 M(-5.2%) | -$23.42 M(+5.9%) |
| June 2019 | - | -$8.37 M(-2.8%) | -$22.12 M(+4.7%) |
| Mar 2019 | - | -$8.60 M(-681.3%) | -$21.12 M(-8.7%) |
| Dec 2018 | -$23.14 M | $1.48 M(-122.3%) | -$23.14 M(-25.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$6.63 M(-9.9%) | -$31.21 M(-0.6%) |
| June 2018 | - | -$7.36 M(-30.7%) | -$31.39 M(+1.5%) |
| Mar 2018 | - | -$10.62 M(+61.1%) | -$30.93 M(+4.1%) |
| Dec 2017 | -$29.73 M(+16.0%) | -$6.59 M(-3.3%) | -$29.73 M(+3.0%) |
| Sept 2017 | - | -$6.82 M(-1.3%) | -$28.86 M(-1.6%) |
| June 2017 | - | -$6.91 M(-26.7%) | -$29.33 M(-1.9%) |
| Mar 2017 | - | -$9.41 M(+64.3%) | -$29.90 M(+16.6%) |
| Dec 2016 | -$25.63 M(+112.7%) | -$5.73 M(-21.2%) | -$25.63 M(+104.3%) |
| Sept 2016 | - | -$7.28 M(-2.7%) | -$12.54 M(+13.0%) |
| June 2016 | - | -$7.48 M(+45.3%) | -$11.10 M(+7.8%) |
| Mar 2016 | - | -$5.15 M(-170.0%) | -$10.29 M(-14.6%) |
| Dec 2015 | -$12.05 M(-52.7%) | $7.36 M(-226.2%) | -$12.05 M(-55.4%) |
| Sept 2015 | - | -$5.83 M(-12.7%) | -$26.99 M(-13.5%) |
| June 2015 | - | -$6.67 M(-3.3%) | -$31.22 M(+7.8%) |
| Mar 2015 | - | -$6.90 M(-9.0%) | -$28.96 M(+13.8%) |
| Dec 2014 | -$25.45 M(+38.9%) | -$7.59 M(-24.5%) | -$25.45 M(+17.2%) |
| Sept 2014 | - | -$10.06 M(+128.0%) | -$21.72 M(-0.7%) |
| June 2014 | - | -$4.41 M(+29.8%) | -$21.87 M(+10.3%) |
| Mar 2014 | - | -$3.40 M(-11.9%) | -$19.83 M(+8.2%) |
| Dec 2013 | -$18.32 M(+136.3%) | -$3.85 M(-62.2%) | -$18.32 M(+26.6%) |
| Sept 2013 | - | -$10.21 M(+330.8%) | -$14.47 M(+239.4%) |
| June 2013 | - | -$2.37 M(+25.1%) | -$4.26 M(+125.1%) |
| Mar 2013 | - | -$1.89 M | -$1.89 M |
| Dec 2012 | -$7.76 M | - | - |
FAQ
- What is Leap Therapeutics annual net profit?
- What is the all time high annual net income for Leap Therapeutics?
- What is Leap Therapeutics annual net income year-on-year change?
- What is Leap Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Leap Therapeutics?
- What is Leap Therapeutics quarterly net income year-on-year change?
- What is Leap Therapeutics TTM net profit?
- What is the all time high TTM net income for Leap Therapeutics?
- What is Leap Therapeutics TTM net income year-on-year change?
What is Leap Therapeutics annual net profit?
The current annual net income of LPTX is -$81.41 M
What is the all time high annual net income for Leap Therapeutics?
Leap Therapeutics all-time high annual net profit is -$7.76 M
What is Leap Therapeutics annual net income year-on-year change?
Over the past year, LPTX annual net profit has changed by -$26.82 M (-49.12%)
What is Leap Therapeutics quarterly net profit?
The current quarterly net income of LPTX is -$18.18 M
What is the all time high quarterly net income for Leap Therapeutics?
Leap Therapeutics all-time high quarterly net profit is $7.36 M
What is Leap Therapeutics quarterly net income year-on-year change?
Over the past year, LPTX quarterly net profit has changed by -$4.48 M (-32.71%)
What is Leap Therapeutics TTM net profit?
The current TTM net income of LPTX is -$64.59 M
What is the all time high TTM net income for Leap Therapeutics?
Leap Therapeutics all-time high TTM net profit is -$1.89 M
What is Leap Therapeutics TTM net income year-on-year change?
Over the past year, LPTX TTM net profit has changed by +$16.46 M (+20.31%)